Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| metyrosine, phenoxybenzamine |
|
|
Term
|
Definition
| anticholinesterase > alcohol |
|
|
Term
|
Definition
|
|
Term
|
Definition
| quaternary ammonium carbamate |
|
|
Term
|
Definition
|
|
Term
|
Definition
| tertiary ammonium carbamate |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| acetylcholinesterase reactivator |
|
|
Term
|
Definition
|
|
Term
|
Definition
| CNS-selective muscarinic blocker |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| tubocurarine, pancuronium, vecuronium |
|
Definition
| competitive NMJ nicotinic blocker |
|
|
Term
|
Definition
| depolarizing NMJ nicotinic blocker |
|
|
Term
|
Definition
|
|
Term
|
Definition
| ganglia nicotinic blocker |
|
|
Term
|
Definition
| ganglia nicotinic blocker |
|
|
Term
| choline ester tx for GI atony and urinary retention |
|
Definition
|
|
Term
| MOA of tx of carbachol vs. timolol for glaucoma |
|
Definition
| carbachol increases humor outflow; timolol decreases humor production |
|
|
Term
| found in mushrooms; tx with atropine |
|
Definition
|
|
Term
| crosses BBB; tx for Alzheimer's |
|
Definition
|
|
Term
| determines tx dosage for myasthenia gravis; tx for NMJ blockers |
|
Definition
|
|
Term
|
Definition
| neostigmine, pyridostigmine, ambenonium |
|
|
Term
| tx for myasthenia gravis, GI disorders, urinary retention, and NMJ blockers |
|
Definition
|
|
Term
|
Definition
| apraclonidine, timolol, carbachol, pilocarpine, physostigmine, demarcarium, echothiophate |
|
|
Term
| tertiary ammonium with CNS and PNS activity |
|
Definition
|
|
Term
|
Definition
|
|
Term
| organophosphate tx for glaucoma |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| tx for organophosphate poisoning |
|
Definition
|
|
Term
| tx for mushroom poisoning |
|
Definition
|
|
Term
| muscarinic blocker that increases HR, no change in BP, but has vagal excitation |
|
Definition
|
|
Term
| muscarinic blocker, high CNS penetration |
|
Definition
|
|
Term
|
Definition
|
|
Term
| indicated for ophthalmic procedures |
|
Definition
|
|
Term
| tx for increase salivation due to Parkinson's or heavy metal poisoning |
|
Definition
|
|
Term
| tx for urinary incontinence |
|
Definition
|
|
Term
| muscarinic blocker for COPD |
|
Definition
|
|
Term
| competitive nicotinic blocker at NMJ |
|
Definition
| tubocurarine, pancuronium, vecuronium |
|
|
Term
| depolarizing nicotinic blocker at NMJ |
|
Definition
|
|
Term
| nicotinic blocker at ganglia |
|
Definition
| hexamethonium, trimethaphan |
|
|
Term
| used to control BP in pts with aortic dissection, hyperreflexia, and to minimize hemorrhage in surgery |
|
Definition
|
|
Term
| stimulates GI and CNS; stimulates then depresses CV and PNS |
|
Definition
|
|
Term
|
Definition
| succinylcholine+halothanes |
|
|
Term
| contraindicated for asthma, hyperthyroidism, coronary insufficiency, peptic ulcer |
|
Definition
|
|
Term
| contraindicated for narrow angle glaucoma |
|
Definition
|
|
Term
| contraindicated for gastric reflux |
|
Definition
|
|
Term
| contraindicated for pts with BPH |
|
Definition
|
|
Term
| muscarinic agonist with some nicotinic activity |
|
Definition
|
|
